The University of Chicago Header Logo

Connection

Mei-Yin Polley to Bortezomib

Back to Details
This is a "connection" page, showing publications Mei-Yin Polley has written about Bortezomib.
Mei-Yin Polley
Connection Strength
0.166
Bortezomib
  1. Randomized trial of ofatumumab and bendamustine versus ofatumumab, bendamustine, and bortezomib in previously untreated patients with high-risk follicular lymphoma: CALGB 50904 (Alliance). Cancer. 2019 10 01; 125(19):3378-3389.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.